Medicine
Amphadase 150 units/mL injection
Amphadase 150 units/mL injection is a prescription medicine containing Hyaluronidase for subcutaneous use, marketed by Amphastar Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store unopened vial in a refrigerator at 2°C to 8°C (36°F to 46° F).
Key facts
- Active ingredient (INN)
- Hyaluronidase
- Brand
- Amphadase
- Strength
- 150 units/mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 10 vials
- Marketing authorisation holder
- Amphastar Pharmaceuticals
- Manufacturer
- Amphastar Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store unopened vial in a refrigerator at 2°C to 8°C (36°F to 46° F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 October 2004
- Identifiers
- RxCUI 238271, 542925DailyMed set ID 8396ea96-7cb5-4e26-87a4-90bca9c3c6ddNDC 0548-9090Application BLA021665
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 0548-9090-10 | Amphastar Pharmaceuticals | 26 October 2004 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Hyaluronidase is an endoglycosidase indicated as an adjuvant, among other approved uses. It is available as injection for subcutaneous use. MedsAcross supplies Hyaluronidase for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about HyaluronidaseFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- AMPHADASE prescribing information (Amphastar Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Amphadase 150 units/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.